Hepatitis B virus infection among illegal drug users in Enugu State, Nigeria: prevalence, immune status, and related risk factors
- PMID: 38724938
- PMCID: PMC11080182
- DOI: 10.1186/s12889-024-18675-8
Hepatitis B virus infection among illegal drug users in Enugu State, Nigeria: prevalence, immune status, and related risk factors
Abstract
Introduction: Hepatitis B virus infection poses a global health challenge, particularly in low- and middle-income African countries. Illicit drug use exacerbates the problem, with drug users having a higher HBV infection risk and maintaining a quiet transmission pool. This study aimed to determine HBV infection prevalence, immune status, and risk factors among illegal drug users in Enugu State, Nigeria.
Materials and methods: A cross-sectional study was conducted in Enugu State, using privileged access interviewer methods to enroll drug users. Pre-tested structured questionnaires were administered after informed consent was obtained. Blood samples were tested for HBsAg, HBsAb, HBeAg, HBeAb, and HBcAb using immunochromatographic rapid test kits. Statistical analysis was performed using SPSS version 25.
Results: One hundred drug users were recruited into the study. Overall, 7% of the drug users had HBV infection. 61% were found to be susceptible to HBV infection, 15% showed serological evidence of immunity from HBV vaccination and 1% developed natural immunity from HBV exposure. Significant risk factors for HBV infection were age less than 20 years, young age (≤ 20 years) at drug initiation, being single, injecting drugs more than or equal to 20 times per month and injecting with used syringes.
Conclusion: This study shows high intermediate endemicity of HBV infection among drug users, low vaccination uptake, and high susceptibility to HBV infection. This calls for the urgent inclusion of drug users in national HBV vaccination campaigns and the adoption of the World Health Organization's recommendations on the prevention of viral hepatitis among people who inject drugs.
Keywords: Drug users; HBV; Illegal; Immunity; Nigeria; Prevalence; Risk factors.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Accessed 24 Jul 2023. file:///C:/Users/USER/Downloads/9789240053779-eng.pdf
-
- Dan-Nwafor CC, Adeoye I, Aderemi K, Onuoha M, Adedire E, Bashorun A et al. Serological markers and risk factors associated with hepatitis B virus infection among federal capital territory prison inmates, Nigeria: should we be concerned? Blackard JT, editor. PLOS ONE. 2021;16(3):e0248045. - PMC - PubMed
-
- United Nations Office on Drug and Crime. World Drug Report. 2022. Accessed 9 Mar 2023. Available from file:///C:/Users/OKONKWO IBUCHUKWU/Downloads/WDR22_Booklet_1.pdf
-
- United Nations Office on Drug and Crime. World Drug Report. 2021. Accessed 9 Mar 2023. https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_1.pdf
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical